Advertisement

Drug Safety

, Volume 31, Issue 5, pp 359–371 | Cite as

Chemotherapy-Associated Osteonecrosis in Cancer Patients with Solid Tumours

A Systematic Review
  • Katharine Shim
  • Mary J. MacKenzie
  • Eric Winquist
Review Article

Abstract

Non-traumatic osteonecrosis of bone is recognized as a potential complication in solid-tumour cancer patients receiving treatment with cytotoxic chemotherapy. This review summarizes recent reports of osteonecrosis associated with chemotherapy in cancer patients, and describes the possible underlying pathophysiology and options available for its diagnosis, prevention and treatment. Fifty-four reported cases of non-traumatic osteonecrosis in adult patients with solid tumours receiving chemotherapy were identified by searching for reports in the medical literature. Osteonecrosis was observed most commonly in men receiving chemotherapy for testicular cancer. Osteonecrosis was also seen in patients receiving chemotherapy for breast, ovarian, small-cell lung cancer and osteosarcoma. Most patients had received corticosteroids, had femoral head involvement and had delayed onset of osteonecrosis. It appears that patients at higher risk for osteonecrosis with chemotherapy are identifiable. As the long-term survival of patients with solid tumours receiving chemotherapy increases, the prevalence of treatment-related osteonecrosis may also increase. Patients should be informed that osteonecrosis is a potential complication of cancer treatment. Measures to reduce risk should be taken, and patients should be monitored for early symptoms. Routine screening for chemotherapy-associated osteonecrosis is not recommended; however, a high index of clinical suspicion in patients at risk may allow for early intervention and preservation of the joints.

Keywords

Femoral Head Osteonecrosis Testicular Cancer Bone Marrow Oedema Severe Acute Respiratory Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors are grateful to Jan Figurski for his assistance with their literature search.

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

References

  1. 1.
    Winquist EW, Bauman GS, Balogh J. Nontraumatic osteonecrosis after chemotherapy for testicular cancer. Am J Clin Oncol 2001; 24: 603–6PubMedCrossRefGoogle Scholar
  2. 2.
    Herbst RS, Bajorin DF, Bleiberg H, et al. Clinical cancer advances 2005: major research advances in cancer treatment, prevention and screening. A report from the American Society of Clinical Oncology. J Clin Oncol 2006; 24: 190–205PubMedCrossRefGoogle Scholar
  3. 3.
    Van Poznak D, Estilo C. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. Oncology (Williston Park) 2006; 20: 1053–62Google Scholar
  4. 4.
    Obrist R, Hartmann D, Obrecht JP. Osteonecrosis after chemotherapy. Lancet 1978; I: 1316CrossRefGoogle Scholar
  5. 5.
    Perloff M, Lesnik GJ. Avascular necrosis of femoral head: association with adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 1980; 64: 361–2PubMedGoogle Scholar
  6. 6.
    Harper PG, Trask C, Souhami RL. Avascular necrosis of bone caused by combination chemotherapy without corticosteroids. BMJ 1984; 288: 267–8PubMedCrossRefGoogle Scholar
  7. 7.
    Marymont JV, Kaufmann EE. Osteonecrosis of bone associated with combination chemotherapy without corticosteroids. Clin Orthop 1986; 204: 150–3PubMedGoogle Scholar
  8. 8.
    Kolin E, Sherry H. Avascular necrosis of the femoral head in patients being treated for malignancy. Mt Sinai J Med 1987; 54: 516–21PubMedGoogle Scholar
  9. 9.
    Meneghello A, Presacco D, Di Maggio C. Aseptic necrosis of the femoral head in cancer patients affected with vincristine/ vinblastine-induced neuropathy [in Italian]. Radiol Med (Torino) 1989; 77: 626–30Google Scholar
  10. 10.
    Wuisman R, Erlemann R, Roessner A, et al. Case report 669. Skeletal Radiol 1991; 20: 294–8PubMedCrossRefGoogle Scholar
  11. 11.
    Forrai G, Baki M, Bodrogi I. Incidence of osteoporosis and aseptic femur head necrosis following complex therapy of germ cell testicular tumors [in Hungarian]. Orv Hetil 1994; 135: 1695–700PubMedGoogle Scholar
  12. 12.
    Jones DN. Multifocal osteonecrosis following chemotherapy and short-term corticosteroid therapy in a patient with small-cell bronchogenic carcinoma. J Nucl Med 1994; 35: 1327–50Google Scholar
  13. 13.
    Gogas H, Fennelly D. Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature. Gynecol Oncol 1996; 63: 379–81PubMedCrossRefGoogle Scholar
  14. 14.
    Besson C, Stelianides S, Belmatoug N, et al. Multifocal osteonecrosis after chemotherapy in a patient with breast cancer. J Rheumatol 1998; 25: 2479–80PubMedGoogle Scholar
  15. 15.
    Cook AM, Patterson H, Nicholls J, et al. Avascular necrosis in patients treated with BEP chemotherapy for testicular tumours. Clin Oncol (R Coll Radiol) 1999; 11: 126–7CrossRefGoogle Scholar
  16. 16.
    Cook AM, Dzik-Jurasz ASK, Padhani AR, et al. The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours. Br J Cancer 2001; 85: 1624–6PubMedCrossRefGoogle Scholar
  17. 17.
    Coles C, Williams M. Avascular necrosis in patients treated with BEP chemotherapy for testicular tumours. Clin Oncol (R Coll Radiol) 2000; 12: 69CrossRefGoogle Scholar
  18. 18.
    Dawson LK, Nussey F, Oliver TB, et al. Osteonecrosis of the femoral head following adjuvant chemotherapy for breast cancer. Breast 2001; 10: 447–9PubMedCrossRefGoogle Scholar
  19. 19.
    Magne N, Foa C, Bruneton JN, et al. Séminome du testicule et osteonécrose aseptique multifocale au décours d’une chimiotherapie. Rev Med Interne 2001; 22: 62–4PubMedCrossRefGoogle Scholar
  20. 20.
    Virik K, Karapetis C, Droufakou S, et al. Avascular necrosis of bone: the hidden risk of glucocorticoids used as antiemetics in cancer chemotherapy. Int J Clin Pract 2001; 55: 344–5PubMedGoogle Scholar
  21. 21.
    Bojko P, Hilger RA, Ruehm SG, et al. Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 31: 487–91PubMedCrossRefGoogle Scholar
  22. 22.
    van den Berkmortel, de Wit R, de Rooy J, et al. Osteronecrosis in patients with testicular tumours treated with chemotherapy. Neth J Med 2004; 62: 23–7PubMedGoogle Scholar
  23. 23.
    Beckmann J, Gotz J, Grifka J, et al. Skaphoidnekrose nach chemotherapie. Orthopade 2005; 34: 938–40PubMedCrossRefGoogle Scholar
  24. 24.
    Kaila R, Wolman RL. Groin pain in athletes: a consequence of femoral head avascular necrosis after testicular cancer chemotherapy. Clin J Sport Med 2006; 16: 175–6PubMedCrossRefGoogle Scholar
  25. 25.
    Jones Jr JP. Coagulopathies and osteonecrosis. Acta Orthop Belg 1999; 65 Suppl. 1: 5–8PubMedGoogle Scholar
  26. 26.
    Assouline-Daya Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002; 32: 94–124Google Scholar
  27. 27.
    Motomura G, Yamamoto T, Miyanishi K, et al. Bone marrow fat-cell enlargement in early steroid-induced osteonecrosis: a histomorphometric study of autopsy cases. Pathol Res Pract 2005; 100: 807–11CrossRefGoogle Scholar
  28. 28.
    Wang G, Cui Q, Balian G. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res 2000; 370: 295–310PubMedCrossRefGoogle Scholar
  29. 29.
    Li X, Jin L, Cui Q, et al. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 2005; 16: 101–8PubMedCrossRefGoogle Scholar
  30. 30.
    Deitcher SR. Cancer and thrombosis: mechanisms and treatment. J Thromb Thrombolysis 2003; 16: 21–31PubMedCrossRefGoogle Scholar
  31. 31.
    Zalavras C, Dailian Z, Elisaf M, et al. Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Eur J Clin Invest 2000; 30: 215–21PubMedCrossRefGoogle Scholar
  32. 32.
    Wada M, Kumagai K, Murata M, et al. Warfarin reduces the incidence of osteonecrosis of the femoral head in spontaneously hypertensive rats. J Orthop Sci 2004; 9: 585–90PubMedCrossRefGoogle Scholar
  33. 33.
    Smith DW. Is avascular necrosis of the femoral head the result of inhibition of angiogenesis? Med Hypotheses 1997; 49: 497–500PubMedCrossRefGoogle Scholar
  34. 34.
    Vadasz Z, Misselevich I, Norman D, et al. Localization of vascular endothelial growth factor during the early reparative phase of the rats’ vessels deprivation-induced osteonecrosis of the femoral heads. Exp Mol Pathol 2004; 77: 145–8PubMedCrossRefGoogle Scholar
  35. 35.
    Yang C, Yang S, Du J, et al. Vascular endothelial growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head of rabbit. Chin Med J 2003; 116: 1544–8PubMedGoogle Scholar
  36. 36.
    Nakame A, Sunagawa T, Ishida O, et al. Acceleration of surgical angiogenesis in necrotic bone with a single injection of fibroblast growth factor-2 (FGF-2). J Orthop Res 2004; 22: 509–13CrossRefGoogle Scholar
  37. 37.
    Hong JM, Kim TH, Chae Sc, et al. Association study of hypoxia inducible factor 1 alpha with osteonecrosis of the femoral head in a Korean population. Osteoarthritis Cartilage 2007; 15(6): 688–94PubMedCrossRefGoogle Scholar
  38. 38.
    Miller KD, Sweeney CJ, Sledge GW. Redefining the target: chemotherapeutics as anti-angiogenics. J Clin Oncol 2001; 19: 1195–206PubMedGoogle Scholar
  39. 39.
    Wong SY, Evans RA, Needs C, et al. The pathogenesis of osteoarthritis of the hip: evidence for primary osteocyte death. Clin Orthop Rel Relat Res 1987; 214: 305–12Google Scholar
  40. 40.
    Spencer JD, Humphreys S, Tighe JR, et al. Early avascular necrosis of the femoral head: report of a case and review of the literature. J Bone Joint Surg Br 1986; 68: 414–7PubMedGoogle Scholar
  41. 41.
    Calder JDF, Buttery L, Revell PA, et al. Apoptosis: a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 2004; 86: 1209–11PubMedCrossRefGoogle Scholar
  42. 42.
    Gangji V, Hauzeur J, Schoutens A, et al. Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheum 2003; 30: 348–50PubMedGoogle Scholar
  43. 43.
    Banfi A, Podest M, Fazzuoli L, et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors. Cancer 2001; 92: 2419–28PubMedCrossRefGoogle Scholar
  44. 44.
    Davies JH, Evans BA, Jenney MEM, et al. In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy. Bone 2002; 31: 319–26PubMedCrossRefGoogle Scholar
  45. 45.
    Xian CJ, Howarth GS, Cool JC, et al. Effects of 5-fluorouracil chemotherapy and insulin-like growth factor-I pretreatment on growth plate cartilage and metaphyseal bone in rats. Bone 2004; 35: 739–49PubMedCrossRefGoogle Scholar
  46. 46.
    Inoue S, Horii M, Asano T, et al. Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation. J Orthop Sci 2003; 8: 751–6PubMedCrossRefGoogle Scholar
  47. 47.
    Fink B, Degenhardt S, Paselk C, et al. Early detection of avascular necrosis of the femoral head following renal transplantation. Arch Orthop Trauma Surg 1997; 116: 151–6PubMedCrossRefGoogle Scholar
  48. 48.
    Koo KH, Kim R, Kim YS, et al. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheum 2002; 21: 299–303CrossRefGoogle Scholar
  49. 49.
    Griffith JF, Antonio GE, Kumta SM, et al. Osteonecrosis of the hip and knee in patients with severe acute respiratory syndrome treated with steroids. Radiology 2005; 235: 168–75PubMedCrossRefGoogle Scholar
  50. 50.
    Steinberg ME, Mont MA. Osteonecrosis. In: Chapman’s orthopaedic surgery. 3rd ed. Philadelphia (PA): Lippincott Williams &Wilkins, 2001: 3263–75Google Scholar
  51. 51.
    Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 2006; 88: 1117–32PubMedCrossRefGoogle Scholar
  52. 52.
    Watson RM, Roach NA, Dalinka MK. Avascular necrosis and bone marrow edema syndrome. Radiol Clin N Am 2004; 42: 207–19PubMedCrossRefGoogle Scholar
  53. 53.
    Radke S, Kenn W, Eulert J. Transient bone marrow edema syndrome progressing to avascular necrosis of the hip: a case report and review of the literature. Clin Rheumatol 2004; 23: 83–8PubMedCrossRefGoogle Scholar
  54. 54.
    Vande Berg BE, Malghem JJ, Labaisse MA, et al. MR imaging of avascular necrosis and transient marrow edema of the femoral head. Radiographics 1993; 13: 501–20PubMedGoogle Scholar
  55. 55.
    Janssens AM, Offner FC, Van Hove WZ. Bone marrow necrosis. Cancer 2000; 88(8): 1769–80PubMedCrossRefGoogle Scholar
  56. 56.
    Mont MA, Ragland PS, Khaled Saleh J, et al. Analysis of classification systems for avascular necrosis of the femoral head [abstract]. J Bone Joint Surg Br 2006; 88-B Suppl. II: 308Google Scholar
  57. 57.
    Gardeniers JWM. Report of the committee of staging and nomenclature. ARCO News Lett 1993; 5: 79–82Google Scholar
  58. 58.
    Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 2001; 386: 173–8PubMedCrossRefGoogle Scholar
  59. 59.
    Jones LC, Hungerford DS. Osteonecrosis: etiology, diagnosis, and treatment. Curr Opin Rheumatol 2004; 16: 443–9PubMedCrossRefGoogle Scholar
  60. 60.
    Hungerford DS, Jones LC. Asymptomatic osteonecrosis. Clin Ortho 2004; 429: 124–30CrossRefGoogle Scholar
  61. 61.
    Hernigou P, Habibi A, Bachir D. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am 2006; 88: 2565–72PubMedCrossRefGoogle Scholar
  62. 62.
    Koo KH, Kim R, Ko GH, et al. Preventing collapse in early osteonecrosis of the femoral head: a randomised clinical trial of core decompression. J Bone Joint Surg Br 1995 Nov; 77(6): 870–4PubMedGoogle Scholar
  63. 63.
    Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002 Dec; (405): 14–23Google Scholar
  64. 64.
    Hernigou P, Poignard A, Manicom O, et al. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 2005; 87: 896–902PubMedCrossRefGoogle Scholar
  65. 65.
    Dhadda AS, Chan S. Bilateral avascular necrosis of the hips after chemoradiotherapy for cervical cancer. Clin Oncol (R Coll Radiol) 2006 Sep; 18(7): 576–7CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  • Katharine Shim
    • 1
  • Mary J. MacKenzie
    • 1
    • 2
  • Eric Winquist
    • 1
    • 2
  1. 1.Schulich School of Medicine and DentistryUniversity of Western OntarioLondonCanada
  2. 2.Division of Medical OncologyUniversity of Western OntarioLondonCanada

Personalised recommendations